Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Could the ASHM have been delayed due to

progress being made on settlement talks between Leckrone and Moore?

From Redbird's post

Response from PTSC IR on Shareholders meeting

posted on Jan 16, 13 01:15PM Use the IP Check tool [?]

I sent PTSC IR an email on when the shareholders meeting will be announced and this was their reply:

Dear XXXX,

We expect to announce the timing for the shareholder meeting soon. We are hoping that the later scheduling of the meeting will afford an opportunity for the further development of matters important to the business to occur

Share
New Message
Please login to post a reply